Oratray lands Greyhill funding for prefilled dental tray platform
What's the deal? Miami-based OratrayDealroom has a profile for this one. Try Dealroom → has raised an undisclosed early-stage equity round led by Greyhill Ventures Oral Care Fund I LPDealroom has a profile for this one. Try Dealroom →, the company said. The deal closed in March 2026 as Oratray advances a prefilled dental tray delivery platform toward regulatory clearance.
What's the endgame? Oratray builds a flexible, mouthguard-shaped tray fitted with burst gel packs that release an active formulation across the teeth and gums when the user bites down. Its first regulated product is a prescription fluoride tray designed to treat tooth sensitivity through dentin tubule occlusion. The company wants to turn a single tray format into a multi-product oral care platform.
Why now? The fluoride tray is moving through the FDA Class II 510(k) pathway under an active pre-submission, but has not been cleared and is not yet for sale in the US. Oratray added a second product after the round closed: the Vitamin E Wellness Tray, a cosmetic and wellness SKU for gum health and post-whitening comfort.
What's next? Oratray expects the Wellness Tray to enter production by the end of 2026, with a commercial launch targeted for the first quarter of 2027. Deliveries tied to the fluoride tray depend on FDA clearance.
The company said it holds granted US patents covering its delivery system, plus patent protection in Europe and an international PCT filing on file. It also reported an order from Teledentistry.comDealroom has a profile for this one. Try Dealroom → valued in the millions of dollars annually, and a letter of intent from Oral GenomeDealroom has a profile for this one. Try Dealroom → for the Wellness Tray.
The signal: Greyhill's Oral Care Fund backs early-stage dental healthcare companies, and managing partner Faizal Javer said the fund invested on the view that the same delivery format can support other actives over time. That points to a broader bet on delivery innovation in oral care, where the treatment goal may be familiar but the user experience remains a barrier.
Read more: theworldnewswire.com
Image credit: Generated with Gemini
